Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/4BB stock hub

AIM/4BB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/4BBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

70.4M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/4BB

In the news

Latest news · AIM/4BB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-209.3

P25 -54.2P50 2.1P75 13.7

ROIC-42.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/4BB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

GBP

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	110
Employees Change	26%
Employees Change Percent	30.95
Enterprise value	GBX 59.7M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BMCLYF79
Last refreshed	2026-05-10
Market cap	GBX 70.4M
Price	GBX 455
Price currency	GBX
Rev Per Employee	16,172.73x
Sector	Healthcare
Sic	2836
Symbol	aim/4BB
Website	https://www.4basebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.46%
EV Earnings	-4.15x
EV/FCF	-4.09x
EV/Sales	33.58x
FCF yield	-20.73%
P/B ratio	3.71x
P/S ratio	39.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	61.55%
Gross Profit	GBX 1.1M
Gross Profit Growth	73.81%
Gross Profit Growth Q	197.03%
Gross Profit Growth3 Y	47.68%
Gross Profit Growth5 Y	35.58%
Net Income	GBX -14.4M
Net Income Growth Years	0%
Pretax Margin	-828.22%
Profit Per Employee	GBX -130,991
ROA	-39.27
Roa5y	-23.19
ROCE	-44.64
ROE	-209.3
Roe5y	-83.15
ROIC	-42.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-59.58%
Cagr3y	-10.51%
Cagr5y	5.39%
EPS Growth Years	0
Revenue Growth	198.49x
Revenue Growth Q	257.93x
Revenue Growth Quarters	5x
Revenue Growth Years	2x
Revenue Growth3 Y	52.06x
Revenue Growth5 Y	46.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.07
Assets	GBX 36.9M
Cash	GBX 26.1M
Current Assets	GBX 28.7M
Current Liabilities	GBX 2.5M
Debt	GBX 15.4M
Debt Equity	GBX 0.81
Debt FCF	GBX -1.06
Equity	GBX 19M
Interest Coverage	-18.58
Liabilities	GBX 17.9M
Long Term Assets	GBX 8.2M
Long Term Liabilities	GBX 15.4M
Net Cash	GBX 10.7M
Net Cash By Market Cap	GBX 15.16
Net Debt Equity	GBX -0.56
Tangible Book Value	GBX 17.7M
Tangible Book Value Per Share	GBX 1.14
WACC	8.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.36
Inventory Turnover	1.54
Net Working Capital	GBX 192,000
Quick ratio	10.38
Working Capital	GBX 26.2M
Working Capital Turnover	GBX 0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-59.56%
200-day SMA	679.9
3Y total return	-28.35%
50-day SMA	511
50-day SMA vs 200-day SMA	50under200
5Y total return	30%
All Time High	1,820
All Time High Change	-75%
All Time High Date	2024-06-18
All Time Low	175
All Time Low Change	160%
All Time Low Date	2021-02-17
ATR	28.53
Beta	0.87
Beta1y	0.06
Beta2y	-0.11
Ch YTD	-26.02
High	460
High52	1,150
High52 Date	2025-06-05
High52ch	-60.43%
Low	455
Low52	450
Low52 Date	2026-05-07
Low52ch	1.11%
Ma50ch	-10.96%
Price vs 200-day SMA	-33.08%
RSI	24.56
RSI Monthly	27.29
RSI Weekly	14.05
Sharpe ratio	-2.57x
Sortino ratio	-2.9
Total Return	-15.92%
Tr YTD	-26.02
Tr1m	-8.82%
Tr1w	-9.9%
Tr3m	-18.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -15.3M
Operating margin	-861.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,679,888%
Net Borrowing	-396,000
Shares Insiders	11.78%
Shares Institutions	40.84%
Shares Out	15,477,395
Shares Qo Q	14.52%
Shares Yo Y	15.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -14.6M
Average Volume	1,504.2x
Bv Per Share	1.23
CAPEX	GBX -831,000
Ch1m	-8.82
Ch1w	-9.9
Ch1y	-59.56
Ch3m	-18.75
Ch3y	-28.35
Ch5y	30
Ch6m	-42.04
Change	-1.09%
Change From Open	-1.09
Close	460
Days Gap	0
Depreciation Amortization	631,000
Dollar Volume	182,910
Earnings Date	2026-05-22
EBIT	GBX -15.3M
EBITDA	GBX -14.7M
EPS	GBX -0.99
F Score	3
FCF	GBX -14.6M
FCF EV Yield	-24.43x
FCF Per Share	GBX -0.94
Financing CF	38,622,000
Fiscal Year End	December
Founded	2,008
Income Tax	GBX -325,000
Investing CF	-1,518,000
Is Primary Listing	1
Last Earnings Date	2026-01-02
Last Report Date	2025-06-30
Ma150	614.7
Ma150ch	-25.98%
Ma20	501
Ma20ch	-9.17%
Net CF	23,396,000
Next Earnings Date	2026-05-22
Open	460
Position In Range	0
Ppne	4,353,000
Price Date	2026-05-08
Ptbv Ratio	3.98
Relative Volume	0.27x
Revenue	1,779,000x
Tax By Revenue	-18.27x
Tr6m	-42.04%
Volume	402
Z Score	3.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/4BB pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/4BB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/4BB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+40.8%

Share of float held by funds and institutions

Insider ownership

+11.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+15.9%

Negative means the company is buying back shares.

Technical

AIM/4BB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.6

Below 30: short-term oversold

Price vs 200-day MA

-33.1%

50/200-day relationship not available

Beta (5Y)

0.87

Moves roughly with the market

Sharpe ratio

-2.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/4BB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/4BB stock rating?

aim/4BB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/4BB analysis?

The full report lives at /stocks/aim/4BB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/4BB?

The latest report frames aim/4BB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/4BB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.